IL98156A - Pharmaceutical preparations containing magnesium-fidoxal-'5-phosphate-glutamine - Google Patents

Pharmaceutical preparations containing magnesium-fidoxal-'5-phosphate-glutamine

Info

Publication number
IL98156A
IL98156A IL9815691A IL9815691A IL98156A IL 98156 A IL98156 A IL 98156A IL 9815691 A IL9815691 A IL 9815691A IL 9815691 A IL9815691 A IL 9815691A IL 98156 A IL98156 A IL 98156A
Authority
IL
Israel
Prior art keywords
phosphate
pyridoxal
glutaminate
ldl
composition according
Prior art date
Application number
IL9815691A
Other languages
English (en)
Hebrew (he)
Other versions
IL98156A0 (en
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of IL98156A0 publication Critical patent/IL98156A0/xx
Publication of IL98156A publication Critical patent/IL98156A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9815691A 1990-05-25 1991-05-16 Pharmaceutical preparations containing magnesium-fidoxal-'5-phosphate-glutamine IL98156A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4016963A DE4016963A1 (de) 1990-05-25 1990-05-25 Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben

Publications (2)

Publication Number Publication Date
IL98156A0 IL98156A0 (en) 1992-06-21
IL98156A true IL98156A (en) 1996-06-18

Family

ID=6407228

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9815691A IL98156A (en) 1990-05-25 1991-05-16 Pharmaceutical preparations containing magnesium-fidoxal-'5-phosphate-glutamine

Country Status (28)

Country Link
US (1) US5372999A (fr)
EP (1) EP0458287B1 (fr)
JP (1) JPH07119174B2 (fr)
KR (1) KR970005180B1 (fr)
CN (1) CN1050750C (fr)
AT (1) ATE142884T1 (fr)
AU (1) AU651108B2 (fr)
CA (1) CA2043228C (fr)
CZ (1) CZ280683B6 (fr)
DE (2) DE4016963A1 (fr)
DK (1) DK0458287T3 (fr)
EG (1) EG19730A (fr)
ES (1) ES2091262T3 (fr)
GR (1) GR3021077T3 (fr)
HR (1) HRP931445B1 (fr)
HU (1) HU219223B (fr)
IE (1) IE76728B1 (fr)
IL (1) IL98156A (fr)
IN (1) IN173057B (fr)
LT (1) LT3335B (fr)
LV (1) LV10046B (fr)
MD (1) MD306C2 (fr)
MX (1) MX171883B (fr)
RU (1) RU2041713C1 (fr)
SI (1) SI9110925A (fr)
SK (1) SK278896B6 (fr)
UA (1) UA26973A1 (fr)
ZA (1) ZA913692B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527820A1 (de) * 1995-07-28 1997-01-30 Leniger Follert Elfriede Prof Arzneimittel zur Behandlung von Ulcera, insbesondere bei arteriellen und venösen Durchblutungsstörungen der Extremitäten, bei chronisch venöser Insuffizienz und Lymphödem
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
AU5840200A (en) * 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (fr) 1999-08-24 2001-03-01 Medicure International Inc. Traitement des pathologies cardio-vasculaires et connexes
DE60110054T2 (de) 2000-02-29 2006-03-09 Medicure International Inc. Cardioprotektive phosphonate
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
NZ523815A (en) 2000-07-07 2004-07-30 Medicure Int Inc Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006050598A1 (fr) 2004-10-28 2006-05-18 Medicure International Inc. Analogues de pyridoxine à double activité anti-plaquettes et anti-coagulantes
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2010535013A (ja) 2007-03-14 2010-11-18 シエラ モレキュラー コーポレイション 細胞および／または高分子の保存および／または安定化のための組成物、システムおよび方法
RU2484843C1 (ru) * 2012-04-03 2013-06-20 Алексей Кириллович Пехтерев Лекарственный сбор растений для лечения сердечно-сосудистых заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246172C (fr)
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker

Also Published As

Publication number Publication date
SI9110925A (sl) 1998-06-30
DE4016963A1 (de) 1991-11-28
CA2043228C (fr) 1998-07-14
US5372999A (en) 1994-12-13
EG19730A (en) 1996-01-31
IL98156A0 (en) 1992-06-21
HRP931445B1 (en) 2000-04-30
ES2091262T3 (es) 1996-11-01
JPH04235130A (ja) 1992-08-24
LTIP580A (en) 1994-12-27
DE4016963C2 (fr) 1992-04-30
HUT58204A (en) 1992-02-28
HRP931445A2 (en) 1996-02-29
IE911783A1 (en) 1991-12-04
EP0458287B1 (fr) 1996-09-18
JPH07119174B2 (ja) 1995-12-20
DK0458287T3 (da) 1996-10-07
CZ280683B6 (cs) 1996-04-17
ATE142884T1 (de) 1996-10-15
AU651108B2 (en) 1994-07-14
SK278896B6 (sk) 1998-04-08
IN173057B (fr) 1994-02-05
LV10046A (lv) 1994-05-10
MX171883B (es) 1993-11-22
UA26973A1 (uk) 2000-02-28
MD306B1 (ro) 1995-10-31
HU219223B (en) 2001-03-28
AU7730191A (en) 1991-11-28
KR970005180B1 (ko) 1997-04-14
LV10046B (en) 1995-02-20
EP0458287A3 (en) 1992-04-08
HU911756D0 (en) 1991-12-30
GR3021077T3 (en) 1996-12-31
MD306C2 (ro) 1996-02-29
RU2041713C1 (ru) 1995-08-20
DE69122170T2 (de) 1997-02-20
EP0458287A2 (fr) 1991-11-27
LT3335B (en) 1995-07-25
CA2043228A1 (fr) 1991-11-26
CS156391A3 (en) 1992-02-19
ZA913692B (en) 1992-02-26
DE69122170D1 (de) 1996-10-24
IE76728B1 (en) 1997-11-05
KR910019616A (ko) 1991-12-19
CN1057391A (zh) 1992-01-01
CN1050750C (zh) 2000-03-29

Similar Documents

Publication Publication Date Title
US5372999A (en) Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions
Nozaki et al. Postheparin lipolytic activity and plasma lipoprotein response to ω-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia
Garg et al. Management of dyslipidemia in NIDDM
JP5827784B2 (ja) ビタミンｋ２を含む医薬及び栄養補助製品
Neuzil et al. The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease
JP2018184463A (ja) スタチン療法中の患者における心血管系イベントの危険性を減少させる方法
Colwell Aspirin therapy in diabetes
CA3147657A1 (fr) Icosapent ethyl pour maintenir le controle des lipoproteines de basse densite
JP2013516457A (ja) Ｖｂ−２０１を用いた併用治療法
KR20010033003A (ko) 스타틴-카르복시알킬에테르 병용 제제
Brattström et al. Pyridoxine reduces cholesterol and low-density lipoprotein and increases antithrombin III activity in 80-year-old men with low plasma pyridoxal 5-phosphate
Ditschuneit et al. Postprandial lipoprotein metabolism in obese patients with moderate hypertriglyceridaemia: effects of gemfibrozil
Gotto Jr et al. The diagnosis and management of hyperlipidemia
Chin-Dusting et al. Lipids and atherosclerosis: clinical management of hypercholesterolaemia
RU2458687C1 (ru) Способ коррекции липопероксидации при гиполипидемической терапии пациентов с метаболическим синдромом
Haines et al. Assessment and management of lipid disorders in men
Beest Overanticoagulation on coumarin anticoagulants
Wohl Body shape, lipid, and cardiovascular complications of HIV therapy
RU2408382C2 (ru) Применение биологически активной добавки к пище "провитам" в качестве ингибитора перекисного окисления липидов
Basit et al. Frequency of statin use in type 2 diabetics having macrovascular disease-at a Tertiary Care Hospital of Karachi
Carr A Young Man with Abdominal Pain and Very High Triglycerides: The Chylomicronemia Syndrome
Verma et al. A Study of Lipid Profile in Hypertension
Colhoun et al. Cholesterol lowering with atorvastatin for the primary prevention of cardiovascular disease in diabetic adults
Kuklinski et al. Interaction between vitamin E and selenium under clinical conditions
Sulaiman et al. Does Vitamin E Improve Hyperlipidemia in Patients with Crdiovascular Disease?

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed